Articles tagged with: Cure
News»

Researchers from the U.S. National Institutes of Health (NIH) recently published what they describe as a "curative blueprint" for myeloma.
The "blueprint" outlines key issues the researchers believe need to be addressed if medical science is to achieve a cure for myeloma.
A crucial question that needs to be answered, the researchers argue, is whether treating "early myeloma" is more advantageous than waiting until the disease has progressed to the symptomatic, or active, stage.
The NIH researchers define "early myeloma" as symptomatic myeloma with limited organ damage, or smoldering multiple myeloma with …
News»

In a recent review article published in the journal Clinical Cancer Research, two myeloma experts from the Dana-Farber Cancer Institute, Dr. Nikhil Munshi and Dr. Kenneth Anderson, review the latest strategies in the treatment of multiple myeloma.
In their article, the experts discuss newer therapies that appear to be promising in clinical and preclinical studies.
According to the physicians, combination therapies that specifically target a patient’s genetic form of the disease will be required for long-term disease control and ultimately a cure.
Some Historical Perspective
In their review article, Drs. Munshi and …
News»

In a recent editorial published in the journal Haematologica, two Spanish myeloma experts, Dr. Jesús San-Miguel and Dr. Maria-Victoria Mateos from the University Hospital of Salamanca, review the progress that has been made in the treatment of multiple myeloma.
More importantly, Drs. San-Miguel and Mateos propose several actions they believe will bring the medical community closer to a cure for myeloma.
These actions include achieving and maintaining the best possible response early in the treatment of the disease, using advanced tools to evaluate and optimize treatment efficacy, and seeking an appropriate balance …
News»

Dr. Kenneth Anderson, a world-renowned myeloma specialist, physician and researcher at Dana-Farber Cancer Institute, and Kraft Family Professor at Harvard Medical School, spoke with The Myeloma Beacon about his approach to treating multiple myeloma patients.
This article is the second part of a two-part series based on The Myeloma Beacon’s interview with Dr. Anderson. It will cover Dr. Anderson’s thoughts on where myeloma treatment is headed in the coming years. For more information on Dr. Anderson’s current approach to treating multiple myeloma, please see part one of this series.
Emerging Therapies …